Johnson & Johnson (JNJ) is a publicly traded Healthcare sector company. As of November 15, 2026, JNJ trades at $285.75 with a market cap of $687.89B and a P/E ratio of 29.05. JNJ moved +1.11% today. Year to date, JNJ is +39.86%; over the trailing twelve months it is +46.35%. Its 52-week range spans $141.50 to $288.11. Analyst consensus is buy with an average price target of $287.88. Rallies surfaces JNJ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
17 analysts cover JNJ: 0 strong buy, 11 buy, 6 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $287.88.
| Metric | Value |
|---|---|
| Price | $285.75 |
| Market Cap | $687.89B |
| P/E Ratio | 29.05 |
| EPS | $8.73 |
| Dividend Yield | 1.34% |
| 52-Week High | $288.11 |
| 52-Week Low | $141.50 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $97.93B |
| Net Income | $21.04B |
| Gross Margin | 67.91% |
17 analysts cover JNJ: 0 strong buy, 11 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $287.88.